Vistagen Therapeutics (VTGN) Leases (2019 - 2025)
Historic Leases for Vistagen Therapeutics (VTGN) over the last 7 years, with Q4 2025 value amounting to $939000.0.
- Vistagen Therapeutics' Leases fell 3572.9% to $939000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $939000.0, marking a year-over-year decrease of 3572.9%. This contributed to the annual value of $1.3 million for FY2025, which is 2664.84% down from last year.
- As of Q4 2025, Vistagen Therapeutics' Leases stood at $939000.0, which was down 3572.9% from $1.1 million recorded in Q3 2025.
- In the past 5 years, Vistagen Therapeutics' Leases ranged from a high of $3.2 million in Q1 2021 and a low of $939000.0 during Q4 2025
- Moreover, its 5-year median value for Leases was $2.1 million (2023), whereas its average is $2.1 million.
- As far as peak fluctuations go, Vistagen Therapeutics' Leases plummeted by 1005.7% in 2021, and later plummeted by 3572.9% in 2025.
- Over the past 5 years, Vistagen Therapeutics' Leases (Quarter) stood at $2.8 million in 2021, then dropped by 14.24% to $2.4 million in 2022, then dropped by 18.21% to $1.9 million in 2023, then fell by 24.44% to $1.5 million in 2024, then plummeted by 35.73% to $939000.0 in 2025.
- Its last three reported values are $939000.0 in Q4 2025, $1.1 million for Q3 2025, and $1.2 million during Q2 2025.